Back to search

Article

The Role of OSM/OSMRβ Axis in Chronic Liver Disease Progression and Hepatocellular Carcinoma Development: A Focus on MASLD/MASH

2026-08-11

Abstract excerpt

Metabolic dysfunction – Associated Steatotic Liver Disease (MASLD) represents the emerging leading cause of Chronic Liver Disease (CLD) worldwide, with a global prevalence of approx. 30% in the general population that parallels global rates of obesity and Type 2 Diabetes (T2D). At present no validated therapy is available to block or slow down disease progression to Metabolic dysfunction – Associated SteatoHepatit...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
84627510-8a73-5775-95ec-6eba36e0ee9b
DOI
10.20944/preprints202608.0645.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The Role of OSM/OSMRβ Axis in Chronic Liver Disease Progression and Hepatocellular Carcinoma Development: A Focus on MASLD/MASHDOI 10.20944/preprints202608.0645.v1
Select a neighboring publication to make it the new centre.